Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy.
Amatore F, Gorvel L, Olive D
Daniel Olive
Team Leader Publications
[Next generation of anti-immune checkpoints antibodies].
Bonnefoy N, Olive D, Vanhove B
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
Chretien AS, Fauriat C, Orlanducci F, Rey J, Borg GB, Gautherot E, Granjeaud S, Demerle C, Hamel JF, Cerwenka A, von Strandmann EP, Ifrah N, Lacombe C, Cornillet-Lefebvre P, Delaunay J, Toubert A, Arnoulet C, Vey N, Olive D